BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17237813)

  • 1. A hidden oncogenic positive feedback loop caused by crosstalk between Wnt and ERK pathways.
    Kim D; Rath O; Kolch W; Cho KH
    Oncogene; 2007 Jul; 26(31):4571-9. PubMed ID: 17237813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation.
    Yun MS; Kim SE; Jeon SH; Lee JS; Choi KY
    J Cell Sci; 2005 Jan; 118(Pt 2):313-22. PubMed ID: 15615777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-Ras is degraded by Wnt/beta-catenin signaling via beta-TrCP-mediated polyubiquitylation.
    Kim SE; Yoon JY; Jeong WJ; Jeon SH; Park Y; Yoon JB; Park YN; Kim H; Choi KY
    J Cell Sci; 2009 Mar; 122(Pt 6):842-8. PubMed ID: 19240121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt signaling pathway has tumor suppressor properties in retinoblastoma.
    Tell S; Yi H; Jockovich ME; Murray TG; Hackam AS
    Biochem Biophys Res Commun; 2006 Oct; 349(1):261-9. PubMed ID: 16930536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
    Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
    Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells.
    Sun J; Jin T
    Cell Signal; 2008 Jan; 20(1):219-29. PubMed ID: 17993259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes.
    Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C
    Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Fodde R; Brabletz T
    Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt and beyond Wnt: multiple mechanisms control the transcriptional property of beta-catenin.
    Jin T; George Fantus I; Sun J
    Cell Signal; 2008 Oct; 20(10):1697-704. PubMed ID: 18555664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational modelling reveals feedback redundancy within the epidermal growth factor receptor/extracellular-signal regulated kinase signalling pathway.
    Orton RJ; Sturm OE; Gormand A; Wolch W; Gilbert DR
    IET Syst Biol; 2008 Jul; 2(4):173-83. PubMed ID: 18681747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
    Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC
    J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reciprocal targeting of Hath1 and beta-catenin by Wnt glycogen synthase kinase 3beta in human colon cancer.
    Tsuchiya K; Nakamura T; Okamoto R; Kanai T; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):208-20. PubMed ID: 17241872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
    Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
    Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells.
    Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG
    Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.
    Chung MT; Lai HC; Sytwu HK; Yan MD; Shih YL; Chang CC; Yu MH; Liu HS; Chu DW; Lin YW
    Gynecol Oncol; 2009 Mar; 112(3):646-53. PubMed ID: 19095296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies.
    Groen RW; Oud ME; Schilder-Tol EJ; Overdijk MB; ten Berge D; Nusse R; Spaargaren M; Pals ST
    Cancer Res; 2008 Sep; 68(17):6969-77. PubMed ID: 18757411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of RAS/β-catenin interactions.
    Zeller E; Hammer K; Kirschnick M; Braeuning A
    Arch Toxicol; 2013 Apr; 87(4):611-32. PubMed ID: 23483189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms.
    Esufali S; Charames GS; Bapat B
    FEBS Lett; 2007 Oct; 581(25):4850-6. PubMed ID: 17888911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.